Form 4 for FULC Fulcrum Therapeutics, Inc.
Accepted 2022-12-29 00:00:00 ET · period of report 2022-12-27 · accession 0001104659-22-130982 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-12-29 | 2022-12-27 | FULC | Kolchinsky Peter | 10% | P - Purchase | $5.99 | +4,089 | 9.51M | +0.0% | +$24.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-27 | P | A | 4,089 | $5.99 | 9,505,925 | I See Footnotes | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $5.98 to $6.00; the price reported above reflects the weighted average purchase price. The reporting person hereby undertakes, upon request, to provide full information to the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer regarding the number of shares and prices at which these transactions, and all other transactions reported in this Form 4, were effected. (F2) Held directly by RA Capital Healthcare Fund, L.P. (the "Fund"). (F3) RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein. |